(26/04/2015)vs
OMS | 00 | 3 | 0 / 00% | 0 / 00% | 1 / 1100% | 1 / 1100% | | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 |
(05/04/2015)vs
ΠΗΓΑΣΟΣ | 00 | 12 | 3 / 3100% | 0 / 00% | 3 / 3100% | 3 / 3100% | | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 |
(21/03/2015)vs
ΝΟΣΤΟΣ | 00 | 12 | 5 / 5100% | 2 / 2100% | 1 / 1100% | 3 / 3100% | | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 |
(15/03/2015)vs
ΑΣΤΡΟΝ ΧΗΜΙΚΑ | 00 | 6 | 0 / 00% | 3 / 3100% | 0 / 00% | 3 / 3100% | | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 |
(08/03/2015)vs
ΟΜΙΛΟΣ ΕΠΙΧΕΙΡΗΣΕΩΝ ΣΑΡΑΚΑΚΗ | 00 | 2 | 0 / 00% | 1 / 1100% | 0 / 00% | 1 / 1100% | | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
(01/03/2015)vs
ΙΑΤΡΙΚΗ ΔΙΑΓΝΩΣΗ ΣΑΛΒΑΡΑ | 22 | 14 | 9 / 1464.3% | 1 / 425% | 1 / 333.3% | 2 / 728.6% | | 1 | 5 | 1 | 6 | 2 | 1 | 0 | 1 | 12 |
(15/02/2015)vs
ΤΙΤΑΝΕΣ | 35 | 2 | 0 / 00% | 1 / 250% | 0 / 70% | 1 / 911.1% | | 1 | 5 | 1 | 6 | 2 | 0 | 0 | 3 | -1 |
(10/02/2015)vs
ΑΣΤΡΟΝ ΧΗΜΙΚΑ | 00 | 0 | 0 / 00% | 0 / 20% | 0 / 40% | 0 / 60% | | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | -5 |
(07/02/2015)vs
ΠΗΓΑΣΟΣ | 26 | 5 | 3 / 650% | 1 / 425% | 0 / 10% | 1 / 520% | | 0 | 1 | 1 | 2 | 5 | 1 | 0 | 1 | 5 |
(01/02/2015)vs
ΝΟΣΤΟΣ | 21 | 3 | 0 / 00% | 0 / 30% | 1 / 520% | 1 / 812.5% | | 2 | 1 | 0 | 1 | 2 | 1 | 0 | 3 | -3 |
| ΣΥΝΟΛΙΚΑ |
104 |
59 |
20 / 2871.4% |
9 / 2142.9% |
7 / 2528% |
16 / 4634.8% |
|
4 |
12 |
4 |
16 |
11 |
3 |
1 |
9 |
43 |
| ΜΕΣΟΙ ΟΡΟΙ |
10.4 |
5.9 |
2 / 2.871.4% |
0.9 / 2.142.9% |
0.7 / 2.528% |
1.6 / 4.634.8% |
|
0.4 |
1.2 |
0.4 |
1.6 |
1.1 |
0.3 |
0.1 |
0.9 |
4.3 |